Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Francais de Chimiotherapie SA
Original Assignee
Laboratoires Francais de Chimiotherapie SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR826343Aexternal-prioritypatent/FR1363858A/fr
Application filed by Laboratoires Francais de Chimiotherapie SAfiledCriticalLaboratoires Francais de Chimiotherapie SA
Priority to FR831769ApriorityCriticalpatent/FR15M/fr
Application grantedgrantedCritical
Publication of FR15MpublicationCriticalpatent/FR15M/fr
C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07J—STEROIDS
C07J75/00—Processes for the preparation of steroids in general
Landscapes
Health & Medical Sciences
(AREA)
Chemical & Material Sciences
(AREA)
General Health & Medical Sciences
(AREA)
Organic Chemistry
(AREA)
Medicinal Chemistry
(AREA)
Pharmacology & Pharmacy
(AREA)
Epidemiology
(AREA)
Life Sciences & Earth Sciences
(AREA)
Animal Behavior & Ethology
(AREA)
Public Health
(AREA)
Veterinary Medicine
(AREA)
FR831769A1960-05-051960-07-01Nouveau médicament notamment pour le traitement des troubles de l'anabolisme protéique et de l'édification cellulaire.
ExpiredFR15M
(fr)
Nouveau médicament notamment pour le traitement des manifestation de l'hypoandrogénie, des troubles de l'anabolisme protidique ainsi que pour le traitement de l'hyperfolliculinie.
Nouveau médicament notamment pour le traitement de l'andropause, de la sénescence et des troubles de l'anabolisme protéique et de l'édification cellulaire.
Nouveau médicament notamment pour le traitement de l'andropause, de la sénescence et des troubles de l'anabolisme protéique et de l'édification cellulaire.
Nouveau médicament, notamment pour le traitement des troubles de l'anabolisme protidique, des manifestations de l'hypoandrogénie et de l'hyperfolliculine.